Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

BACKGROUND: Direct-acting antivirals have been used for decompensated cirrhotic patients with hepatitis C virus (HCV) infection. However, the benefits in Chinese patients with decompensated cirrhosis are unclear. METHODS: Thirty patients with HCV infection and decompensated cirrhosis were administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Fanpu, Wang, Wenjun, Dang, Shuangsuo, Wang, Shengbang, Li, Burong, Bai, Dan, Zhao, Wenxue, Deng, Hong, Tian, Changyin, Li, Zongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598030/
https://www.ncbi.nlm.nih.gov/pubmed/28924449
http://dx.doi.org/10.1186/s13027-017-0158-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598030/
https://www.ncbi.nlm.nih.gov/pubmed/28924449
http://dx.doi.org/10.1186/s13027-017-0158-1

Ejemplares similares